Project Number 3U01AG060965-02S1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Repurposing of Universal and Immunogenic MultiTEP Platform Designed for AD to Develop SARS-CoV-2 Multiepitope Vaccine Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator AGADJANYAN, MICHAEL G Principal Investigator First Name MICHAEL G Principal Investigator Last Name AGADJANYAN Awardee Organization INSTITUTE FOR MOLECULAR MEDICINE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $389,064 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
